CIK 0001933414
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Mineralys Therapeutics, Inc.
Sign in to watch- Ticker
- MLYS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 841966887
- Phone
- +1 888-378-6240
- Business address
- 150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,209,843
- in 4 filings, $2.2M under 10b5-1 plans
Net −$5,209,843. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-05 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −67,473 | 108,334 | ||
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +10,053 | $1.08 | $11K | 81,888 |
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +3,629 | $15.44 | $56K | 85,517 |
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +9,347 | $10.20 | $95K | 94,864 |
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +20,168 | $16.00 | $323K | 115,032 |
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +24,193 | $14.25 | $345K | 139,225 |
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −70,037 | $35.87 | $2.5M | 69,188 |
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −10,053 | 72,478 | ||
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −3,629 | 16,371 | ||
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −9,347 | 160,653 | ||
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −20,168 | 84,018 | ||
| 2026-01-02 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −24,193 | 175,807 | ||
| 2025-10-15 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −10,369 | $43.01 | $446K | 71,155 |
| 2025-09-15 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −9,302 | $35.90 | $334K | 83,589 |
| 2025-09-15 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −2,065 | $36.47 | $75K | 81,524 |
| 2025-08-13 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −11,365 | $12.93 | $147K | 92,891 |
| 2025-08-12 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +6,349 | $1.08 | $7K | 104,256 |
| 2025-08-12 | Rodman David Malcom Chief Medical Officer | Exercise or conversion · Stock Option 10b5-1 | −6,349 | 82,531 | ||
| 2025-07-14 | Rodman David Malcom Chief Medical Officer | Exercise or conversion 10b5-1 | +6,349 | $1.08 | $7K | 109,273 |
| 2025-07-14 | Rodman David Malcom Chief Medical Officer | Sale 10b5-1 | −11,366 | $14.59 | $166K | 97,907 |
Page 7 of 12 · 239 trades